Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

MDxHealth (MDXH) Net Margin (2021 - 2025)

Historic Net Margin for MDxHealth (MDXH) over the last 5 years, with Q3 2025 value amounting to 29.24%.

  • MDxHealth's Net Margin rose 158400.0% to 29.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year increase of 487000.0%. This contributed to the annual value of 33.72% for FY2024, which is 276800.0% up from last year.
  • Per MDxHealth's latest filing, its Net Margin stood at 29.24% for Q3 2025, which was up 158400.0% from 0.01% recorded in Q2 2025.
  • In the past 5 years, MDxHealth's Net Margin ranged from a high of 296959.74% in Q2 2022 and a low of 138.69% during Q3 2021
  • Moreover, its 5-year median value for Net Margin was 52.02% (2024), whereas its average is 17402.4%.
  • Data for MDxHealth's Net Margin shows a peak YoY increase of 804100bps (in 2023) and a maximum YoY decrease of 2000000000bps (in 2023) over the last 5 years.
  • Quarter analysis of 5 years shows MDxHealth's Net Margin stood at 134.41% in 2021, then increased by 30bps to 94.5% in 2022, then surged by 42bps to 55.25% in 2023, then skyrocketed by 51bps to 27.26% in 2024, then dropped by -7bps to 29.24% in 2025.
  • Its Net Margin stands at 29.24% for Q3 2025, versus 0.01% for Q2 2025 and 36.78% for Q1 2025.